Your shopping cart is currently empty

(S)-Mapracorat is a selective and less active agonist of the glucocorticoid receptor.


| Description | (S)-Mapracorat is a selective and less active agonist of the glucocorticoid receptor. |
| In vivo | During the 60-minute observation period, intradermal injection of compound 48/80 (50 μg in 50 μL saline) resulted in a significant wheal and flare reaction. Topical pre-treatment with (S)-Mapracorat (0.1%) leads to significant reduction in the wheal and flare responses compared to vehicle (acetone) treated areas. |
| Synonyms | (S)-ZK-245186, (S)-BOL-303242X |
| Molecular Weight | 462.48 |
| Formula | C25H26F4N2O2 |
| Cas No. | 887375-15-7 |
| Smiles | Cc1ccc2c(NC[C@@](O)(CC(C)(C)c3cc(F)cc4CCOc34)C(F)(F)F)cccc2n1 |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50.6 mg/mL (109.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.